HEPATOCELLULAR CARCINOMA AFTER DIRECT ANTIVIRAL AGENTS FOR HEPATITIS C IN PATIENTS WITH DECOMPENSATED CIRRHOSIS

HEPATOCELLULAR CARCINOMA AFTER DIRECT ANTIVIRAL AGENTS FOR HEPATITIS C IN PATIENTS WITH DECOMPENSATED CIRRHOSIS

Introduction and Objectives: If direct antiviral agents (DAA) are related to the development of HCC is controversial; therefore, exploring risk factors are crucial. We aimed to determine factors related to the development of hepatocellular carcinoma (HCC) in patients with hepatitis c (HCV) and decom...

Full description

Bibliographic Details
Main Authors:	F- Higuera-de-la-Tijera, N.C. Flores-García, D. Kershenobich, E. Cerda-Reyes, M.S. González-Huezo, J.L. Pérez-Hernández, N. Méndez-Sánchez, O. Morales-Gutiérrez, J.E. Lira-Vera, P. Alagón-Fernández-del-Campo, F.Y. Vargas-Durán, K. Soto-Martínez, G.M.L. Guerrero-Avendaño, A. Servín-Caamaño, J.G. Gándara-Calderón, D. García-Domínguez, L.E. Díaz-Orozco, N. García-Casarreal, S. Mejía-Loza, I.B. Lázaro-Pacheco, E. Rodríguez-Fuentes
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Annals of Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268121003094

Similar Items

A MULTICENTER REAL-WORLD COHORT TO VALIDATE THE EFFICACY AND SAFETY OF DIRECT ANTIVIRAL AGENTS FOR HEPATITIS C, AND RELATED RISK FACTORS FOR NON-SVR IN DECOMPENSATED CIRRHOSIS
by: F. Higuera-de-la-Tijera, et al.
Published: (2022-01-01)

CHANGES IN CARDIAC FUNCTION IN PATIENTS WITH DECOMPENSATED CHRONIC LIVER FAILURE
by: M.E. Robles-Villagómez, et al.
Published: (2022-01-01)

CAUSES OF DECOMPENSATION IN HOSPITALIZED CIRRHOTIC PATIENTS
by: A.B. Moreno-Cobos, et al.
Published: (2022-01-01)

Hepatocelullar carcinoma is a major risk factor for the development of portal ven thrombosis in cirrhotic patients
by: C.A. Espinoza, et al.
Published: (2020-09-01)

Comparison of the meld-la model as a predictor of early mortality in Mexican patients with chronic decompensated liver disease
by: A Enríquez-Constantino, et al.
Published: (2022-12-01)

Screening program for hepatitis c virus in an open population at a third-level healthcare center
by: F Higuera-de la Tijera, et al.
Published: (2022-12-01)

Prevalence and characteristics of cirrhotic patients with portal vein thrombosis admited in the Gastroenterology Department of the Hospital General de Mexico
by: C.A. Campoverde-Espinoza, et al.
Published: (2020-09-01)

Malnutrition is related to a higher frequency of serious complications in patients with cirrhosis
by: E. Pérez-Reyes, et al.
Published: (2016-01-01)

Prevalence of high-risk non-alcoholic steatohepatitis according to the fast® index in a group of diabetic patients
by: A Burak-Leipuner, et al.
Published: (2022-12-01)

Main clinical factors influencing early mortality in a cohort of patients with severe alcoholic hepatitis, and evaluation trough ROC curves of different prognostic scoring systems
by: Fátima Higuera-de la Tijera, et al.
Published: (2014-10-01)

Prevalence of fibrosis and steatosis determined by transition elastography and controlled attenuation parameter (fibroscanâ) in diabetic patients
by: A Burak-Leipuner, et al.
Published: (2022-12-01)

PROTON PUMP INHIBITORS INCREASE THE OVERALL RISK OF DEVELOPING BACTERIAL INFECTIONS IN PATIENTS WITH CIRRHOSIS
by: Illce B LÁZARO-PACHECO, et al.

CORRELATION BETWEEN SARCOPENIA AND HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS
by: O. Morales Gutiérrez, et al.
Published: (2022-01-01)

IGFBP-1 TO 7 AS BIOMARKERS IN STAGES OF LIVER FIBROSIS DURING VIRAL HEPATITIS C
by: M. Martínez-Castillo, et al.
Published: (2022-01-01)

FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY
by: V. N. Larina, et al.
Published: (2015-09-01)

“CYTOKINE” MODEL OF PATHOGENESIS OF CHRONIC HEART FAILURE AND THE OPPORTUNITIES OF NEW THERAPEUTIC STRATEGY IN DECOMPENSATED PATIENTS
by: U. A. Vasuk, et al.
Published: (2016-01-01)

Left-sided portal hypertension as a complication of chronic pancreatitis in a young patient. A case report
by: CL Dorantes-Nava, et al.
Published: (2022-12-01)

Treatment with Metadoxine and its impact on early mortality in patients with severe alcoholic hepatitis
by: Fátima Higuera-de la Tijera, et al.
Published: (2014-05-01)

Haemodynamic effects of aliskiren in decompensated severe heart failure
by: Euler O Brancalhao, et al.
Published: (2012-03-01)

Sofosbuvir-velpatasvir en pacientes mexicanos con hepatitis C: una revisión retrospectiva
by: J.L. Pérez-Hernández, et al.
Published: (2022-01-01)

INCIDENTAL FINDING OF FATTY LIVER IN AUTOPSIES
by: I.E. Bravo-Espinoza, et al.
Published: (2022-01-01)

Incidental finding of fatty liver in necropsies
by: I.E. Bravo-Espinoza, et al.
Published: (2020-09-01)

Integral assessment of congestion in patients with acute decompensated heart failure
by: Zh. D. Kobalava, et al.
Published: (2022-03-01)

Some practical issues in the management of patients with decompensated liver cirrhosis
by: E A Fedosina, et al.
Published: (2019-08-01)

Optimization of intravascular volume determination in patients with acute decompensated heart failure
by: I. V. Zhirov, et al.
Published: (2022-06-01)

SERUM DETERMINATION OF MMP-2 AND MMP-9 ACCORDING TO THE PATTERN OF ALCOHOL CONSUMPTION AND IN ALCOHOLIC HEPATIC DISEASE
by: A. Hernandez-Barragan, et al.
Published: (2022-01-01)

Prognostic impact of uric acid in patients with acute decompensated heart failure
by: Svetlana N. Nasonova, et al.
Published: (2021-09-01)

Suboptimal metabolic control and decompensation in children and adolescents with diabetes mellitus type 1
by: N. Ya. Filina, et al.
Published: (2016-10-01)

LILLE-4 vs. LILLE-7 to predict short-term mortality in patients with severe alcoholic hepatitis
by: Claudia L. Dorantes-Nava, et al.
Published: (2024-02-01)

Clinico-demographic characteristics of the patients with decompensated chronic heart failure Clinico-demographic characteristics of the patients with decompensated chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (2011-04-01)

Acute decompensation of heart failure: state of the problem
by: Igor V. Zhirov, et al.
Published: (2022-10-01)

Buschke-Lowenstein tumor in a patient with decompensated cirrhosis
by: F. N. U. Shailesh, et al.
Published: (2014-01-01)

Urinary tract infections in patients with decompensated liver cirrhosis, listed for liver transplantation
by: P. D. Bessonov, et al.
Published: (2018-08-01)

Respiratory Muscles Training in the Complex Treatment of Patients with Acute Decompensated Heart Failure
by: N. T. Vatutin, et al.
Published: (2022-02-01)

Prevention of chronic kidney disease progression in patients with acute decompensation of chronic heart failure
by: V. V. Davydov, et al.
Published: (2019-04-01)

Acute kidney injury worsens outcomes in acute decompensation of chronic heart failure
by: V. V Davydov, et al.
Published: (2017-12-01)

MELD Na and MELD 3.0 have the best performance in predicting the risk of death at 28 days in patients with severe alcoholic hepatitis in the Mexican population
by: CL Dorantes-Nava, et al.
Published: (2022-12-01)

SGLT2 inhibitors in acute decompensated heart failure, what do we know?
by: Anastasiya E. Lapteva, et al.
Published: (2022-05-01)

Asociación Mexicana de Hepatología A.C. Guía Clínica de Hepatitis B
by: F. Higuera-de-la-Tijera, et al.
Published: (2021-10-01)

Sick sinus syndrome: decompensation prevention
by: V. M. Provotorov, et al.
Published: (2004-12-01)